Essa M. Saied | Genetics and Molecular Biology | Research Excellence Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Essa M. Saied | Genetics and Molecular Biology | Research Excellence Award

Associate Professor | Humboldt Universität zu Berlin | Germany

Dr. Essa M. Saied is a distinguished researcher at Suez Canal University, Egypt, specializing in medicinal chemistry, molecular pharmacology, and plant genetics. His work focuses on multi-target therapeutic strategies, anticancer drug design, and genetic and epigenetic mechanisms underlying crop resilience. Dr. Saied has authored numerous high-impact publications in leading journals, contributing significantly to advancements in both human health and agricultural sciences. His research integrates in vitro, in vivo, and in silico approaches, fostering innovative solutions for disease management and food security. With extensive collaborations across international research networks, he has advanced knowledge translation from laboratory discoveries to practical applications. His work has had a notable societal impact, particularly in promoting global health, sustainable agriculture, and biofortification strategies.

Citation Metrics (Scopus)

2,248
1500
1000
500
0

Citations

2,248

Documents

72

h-index

31

Citations

Documents

h-index

View Google Scholar Profile
 View Scopus Profile
 View ORCID Profile

Featured Publications

Hywel Williams | Genomic Medicine | Best Researcher Award

Published on by Global Scholar Awards

Dr. Hywel Williams | Genomic Medicine | Best Researcher Award

Senior Lecturer | Cardiff University | United Kingdom

Dr. Hywel J. Williams is a distinguished academic and researcher currently serving as a Senior Lecturer in Bioinformatics: Genetic and Genomic Medicine in the Division of Cancer and Genetics, School of Medicine, Cardiff University, since 2019. He holds a Ph.D. in Genetics from Cardiff University (2001–2005), where his research focused on identifying schizophrenia susceptibility genes on chromosome 22 under the supervision of Prof. Sir Michael J. Owen. His earlier academic qualifications include a B.Sc. (Hons) in Genetics from Cardiff University (1994–1996) and an HND in Applied Biology from the University of Wales Institute Cardiff (1992–1994). Dr. Williams also earned recognition as an Associate Fellow of the Higher Education Academy in 2018. With over two decades of research experience, his career spans roles such as Senior Research Associate at UCL’s Great Ormond Street Institute of Child Health (2013–2018), and various research positions at Cardiff University from 1997 to 2012. His work integrates bioinformatics, genomics, and molecular genetics, with a primary focus on rare diseases, psychiatric genetics, and genomic medicine. His key contributions include joint first authorship of the landmark study “The 100,000 Genomes Pilot on Rare Disease Diagnosis in Healthcare” published in the New England Journal of Medicine (2021), and senior authorship in studies enhancing rapid pediatric sequencing and understanding of genetic disorders. Dr. Williams possesses advanced research skills in genomic data analysis, variant interpretation, computational biology, and multi-omic integration, contributing to the clinical translation of genome sequencing technologies. With an outstanding academic record—over 19,000 citations, an h-index of 56, and an i10-index of 101—he is recognized for his influential work in genomic research and data-driven healthcare. His career reflects a commitment to improving diagnostic accuracy and patient care through innovative bioinformatics approaches, making him a key contributor to the global advancement of precision and personalized medicine.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O’Donovan, M. C., Sullivan, P. F., Williams, H. J., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748–752. https://doi.org/10.1038/nature08185 Cited by: 5,521

  2. Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics, 43(10), 969–976. https://doi.org/10.1038/ng.940 Cited by: 2,110

  3. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature, 506(7487), 179–184. https://doi.org/10.1038/nature12929 Cited by: 1,920

  4. O’Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics, 40(9), 1053–1055. https://doi.org/10.1038/ng.201 Cited by: 1,327

  5. 100,000 Genomes Project Pilot Investigators (including Williams, H. J.). (2021). 100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report. New England Journal of Medicine, 385(20), 1868–1880. https://doi.org/10.1056/NEJMoa2035790 Cited by: 657

Hao Wu | Protein engineering | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Hao Wu | Protein engineering | Best Researcher Award

Teacher  at Changsha University of Science and Technology, China

Dr. Hao Wu is a highly qualified researcher with a Ph.D. in Microbiology and extensive postdoctoral experience. Currently serving as an Associate Professor at Changsha University of Science & Technology, his research focuses on food biotechnology, protein engineering, and synthetic biology, particularly in the development of anti-diabetic compounds, enzyme engineering, and the production of human milk oligosaccharides. With over 20 publications in high-impact journals and leadership in numerous first-author and corresponding author roles, Dr. Wu has made significant contributions to applied food science and biotechnology. His work on enzyme stability and microbial fermentation has direct industrial and health-related implications. Additionally, he is actively involved in peer review and editorial positions for several prestigious journals. While his profile would benefit from further recognition through awards and major project leadership, his impressive publication record and research contributions make him a strong contender for the Best Researcher Award.

Professional Profile 

Education🎓

Dr. Hao Wu holds a Ph.D. in Microbiology, which he earned in 2019 from Guangxi University in Nanning, Guangxi, China. He also completed his Bachelor of Science in Bioengineering at Guangxi University in 2013. His academic background provides a solid foundation for his current research, bridging microbiology, biotechnology, and food science. During his doctoral studies, Dr. Wu specialized in the molecular aspects of food biotechnology and protein engineering, laying the groundwork for his postdoctoral research at Jiangnan University. This advanced training has been crucial in shaping his research focus on the production of anti-diabetic compounds, enzyme modification, and synthetic biology applications. Throughout his academic journey, Dr. Wu has gained a strong grasp of both theoretical and practical aspects of bioengineering, allowing him to make significant contributions to the field of food biotechnology. His educational path reflects a deep commitment to advancing the understanding of microbiology and food science.

Professional Experience📝

Dr. Hao Wu has a rich professional background, combining research and teaching roles in the field of food biotechnology. After completing his Ph.D., he gained postdoctoral experience at Jiangnan University, where he advanced his research in protein engineering and microbial fermentation techniques. In December 2021, Dr. Wu joined Changsha University of Science & Technology as an Associate Professor in the School of Food Science and Bioengineering, where he has continued his research on food biotechnology, synthetic biology, and enzyme engineering. His work focuses on developing innovative solutions such as producing anti-diabetic compounds through microbial fermentation and engineering enzymes for the production of functional sugars and sugar alcohols. Dr. Wu’s role as a professor also involves mentoring graduate students and contributing to the university’s research initiatives. His experience as a peer reviewer and editorial board member for numerous scientific journals further highlights his active engagement in the scientific community.

Research Interest🔎

Dr. Hao Wu’s research interests are centered around food biotechnology, protein engineering, fermentation engineering, and synthetic biology. His work focuses on the development of potential anti-diabetic compounds through microbial fermentation techniques, employing methods such as microbial mutation breeding and fermentation process control. Additionally, Dr. Wu is dedicated to the molecular modification of enzymes, particularly in improving their thermal stability, catalytic activity, and substrate specificity for the production of functional sugars and sugar alcohols. Another key area of his research involves using cutting-edge synthetic biological technologies, including gene editing and metabolic engineering, to design and construct efficient cell factories for producing human milk oligosaccharides. His innovative approaches aim to address pressing challenges in the food industry, including the creation of healthier food ingredients and more sustainable production methods. Dr. Wu’s interdisciplinary expertise allows him to make significant contributions to both the scientific community and the applied biotechnology sector.

Award and Honor🏆

Dr. Hao Wu has earned several notable awards and honors throughout his academic and professional career, reflecting his outstanding contributions to the fields of food biotechnology and microbiology. As a leading researcher in the production of functional food ingredients and enzyme engineering, he has gained recognition for his innovative work, particularly in developing anti-diabetic compounds through microbial fermentation and engineering enzymes with improved properties. His research has been widely published in prestigious journals, and his work has attracted significant attention from the scientific community. Dr. Wu’s leadership extends beyond research, as he serves as a peer reviewer for numerous scientific journals, such as Journal of Agricultural and Food Chemistry and Critical Reviews in Food Science and Nutrition. His expertise has also led to editorial roles, including membership on the editorial boards of Food Science and Human Wellness and Journal of Future Foods, further demonstrating his respected status in the field.

Research Skill🔬

Dr. Hao Wu possesses a diverse set of research skills that have significantly contributed to his success in food biotechnology and microbiology. His expertise spans several advanced techniques, including microbial fermentation, protein engineering, and enzyme modification. Dr. Wu is proficient in employing microbial mutation breeding and fermentation process control to produce bioactive compounds, particularly for anti-diabetic applications. His work in molecular modification of enzymes focuses on improving their thermal stability, catalytic activity, and substrate specificity, using cutting-edge approaches like computational design and rational engineering. In addition, Dr. Wu is well-versed in synthetic biology techniques, such as gene editing and metabolic engineering, which he uses to design high-efficiency cell factories for the production of human milk oligosaccharides. His ability to integrate various biotechnological methodologies, along with his comprehensive understanding of biochemistry, enables him to address complex challenges and make innovative contributions to both the scientific community and the food industry.

Conclusion💡

Dr. Hao Wu is a strong candidate for the Best Researcher Award, particularly due to his:

  • High-quality publications,

  • Pioneering work in enzyme and metabolic engineering,

  • Leadership in synthetic biology applications for food science, and

  • Active contribution to the academic community through editorial roles.

If complemented by evidence of major grant leadership, mentorship of young researchers, and international academic visibility, his candidacy would be even more compelling.

Publications Top Noted✍️

  • Research Progress on the Preparation and Function of Antioxidant Peptides from Walnuts

    • Authors: Yuxi Hu, Ce Ni, Yingying Wang, Xun Yu, Hao Wu, Jia Tu, Changzhu Li, Zhihong Xiao, Li Wen

    • Year: 2023

    • Citation: International Journal of Molecular Sciences, DOI: 10.3390/ijms241914853

  • D-allulose, a Versatile Rare Sugar: Recent Biotechnological Advances and Challenges

    • Authors: Wenli Zhang, Ding Chen, Jiajun Chen, Wei Xu, Qiuming Chen, Hao Wu, Cuie Guang, Wanmeng Mu

    • Year: 2023

    • Citation: Critical Reviews in Food Science and Nutrition, DOI: 10.1080/10408398.2021.2023091

  • Engineering the Thermostability of D-lyxose Isomerase from Caldanaerobius Polysaccharolyticus via Multiple Computer-Aided Rational Design for Efficient Synthesis of D-Mannose

    • Authors: Hao Wu, Ming Yi, Xiaoyi Wu, Yating Ding, Minghui Pu, Li Wen, Yunhui Cheng, Wenli Zhang, Wanmeng Mu

    • Year: 2023

    • Citation: Synthetic and Systems Biotechnology, DOI: 10.1016/j.synbio.2023.04.003

  • Overview of Strategies for Developing High Thermostability Industrial Enzymes: Discovery, Mechanism, Modification and Challenges

    • Authors: Hao Wu, Qiuming Chen, Wenli Zhang, Wanmeng Mu

    • Year: 2023

    • Citation: Critical Reviews in Food Science and Nutrition, DOI: 10.1080/10408398.2021.1970508

  • Alanine Substitution to Determine the Effect of LR5 and YR6 Rice Peptide Structure on Antioxidant and Anti-Inflammatory Activity

    • Authors: Yun-Hui Cheng, Bu-Qing Liu, Bo Cui, Li Wen, Zhou Xu, Mao-Long Chen, Hao Wu

    • Year: 2023

    • Citation: Nutrients, DOI: 10.3390/nu15102373

  • Recent Development of Phenyllactic Acid: Physicochemical Properties, Biotechnological Production Strategies and Applications

    • Authors: Hao Wu, Cuie Guang, Wenli Zhang, Wanmeng Mu

    • Year: 2023

    • Citation: Critical Reviews in Biotechnology, DOI: 10.1080/07388551.2021.2010645

  • Application Prospects and Opportunities of Inorganic Nanomaterials for Enzyme Immobilization in the Food-Processing Industry

  • Glycosyltransferase from Bacteroides Gallinaceum Is a Novel α-1,3-Fucosyltransferase That Can Be Used for 3-Fucosyllactose Production In Vivo by Metabolically Engineered Escherichia Coli

    • Authors: Geng Chen, Hao Wu, Yingying Zhu, Li Wan, Wenli Zhang, Wanmeng Mu

    • Year: 2022

    • Citation: Journal of Agricultural and Food Chemistry, DOI: 10.1021/acs.jafc.1c06719

  • D-Mannose-Producing Isomerases and Epimerases: Properties, Comparisons, and Different Strategies

  • L-Arabinose Isomerase: Sources, Biochemical Properties, and Its Use to Produce D-Tagatose

  • Engineering Escherichia Coli for Highly Efficient Production of Lacto-N-triose II from N-acetylglucosamine, the Monomer of Chitin

  • Efficient Control of Acrylamide in French Fries by an Extraordinarily Active and Thermo-Stable L-Asparaginase: A Lab-Scale Study

  • Microbial Production, Molecular Modification, and Practical Application of L-Asparaginase: A Review

  • Metabolic Engineering of Escherichia Coli for Efficient Biosynthesis of Lacto-N-tetraose Using a Novel β-1,3-Galactosyltransferase from Pseudogulbenkiania Ferrooxidans

  • Metabolic Engineering of Escherichia Coli for Lacto-N-triose II Production with High Productivity

Gareth Baynam | Genetics | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Gareth Baynam | Genetics | Best Researcher Award

Medical Director  at The Rare Care Centre, Perth Children’s Hospital, Australia

Clinical Professor Gareth Baynam is a globally recognized leader in rare diseases, precision public health, and equitable healthcare innovation. With over two decades of experience as a clinical geneticist and translational scientist, he holds numerous influential roles across academia, healthcare policy, and genomics research, including Director of the Undiagnosed Diseases Network International and Medical Director of the Rare Care Centre in Western Australia. His work focuses on advancing health equity, particularly for children, Indigenous populations, and those with rare diseases. Gareth has pioneered several international collaborations and state-wide initiatives, transforming research into sustainable clinical applications. His influential publications and numerous accolades, including the Western Australia Minister for Health’s Award and recognition from the Genetic and Rare Diseases Network, underscore his profound impact on healthcare systems and patient communities. His innovative, inclusive, and patient-centered approach makes him a strong and highly suitable candidate for the Best Researcher Award.

Professional Profile 

Education🎓

Professor Gareth Baynam possesses an impressive and multidisciplinary educational background that underpins his impactful career in clinical genetics and public health innovation. He obtained his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Western Australia in 1997, followed by a Diploma in Child Health (DCH) in 1999. He earned his Fellowship from the Royal Australasian College of Physicians (FRACP) in 2001, specializing in Medicine. Driven by a passion for translational research, he completed a Ph.D. in Vaccine Genetics at the University of Western Australia in 2008, further strengthening his foundation in genomic science. In 2020, he also became an Associate Fellow of the Australasian Institute of Digital Health (A/FAIDH), reflecting his commitment to health informatics and digital health transformation. His comprehensive education equips him with the clinical, scientific, and technological expertise necessary to lead innovative healthcare initiatives and influence global health policies, particularly in rare disease research and precision medicine.

Professional Experience📝

Professor Gareth Baynam has a distinguished professional career that spans clinical practice, academic leadership, health policy, and global research collaboration. Since 2008, he has served as a Clinical Geneticist at Genetic Services of Western Australia, where he provides expert care and contributes to advancing genetic medicine. He held the position of Raine Clinician Research Fellow from 2014 to 2019, a prestigious role that allowed him to bridge clinical service with impactful research. He has served as a Clinical Associate Professor and later Clinical Professor at the University of Western Australia, and also holds academic appointments at Curtin University, the University of Notre Dame, and serves on multiple national and international advisory boards. As Medical Director of the Rare Care Centre and Director of the Undiagnosed Diseases Network International, he leads innovative initiatives in rare disease diagnosis and care. His professional journey is marked by a deep commitment to equitable healthcare and translational genomics.

Research Interest🔎

Professor Gareth Baynam’s research interests lie at the intersection of clinical genetics, precision public health, and equitable healthcare delivery. He is particularly passionate about improving outcomes for individuals with rare diseases, birth defects, and cerebral palsy, with a strong focus on Indigenous and underserved communities. His work emphasizes the use of innovative technologies—ranging from ancient knowledge systems to modern genomics and digital health—to develop sustainable, patient-centered healthcare solutions. He is a pioneer in translational science, transforming cutting-edge research into real-world clinical applications through deep community engagement and multi-sector partnerships. Professor Baynam also plays a critical role in shaping health policy and genomic strategies at national and global levels. His efforts support the integration of precision medicine into primary care systems and promote health equity through public-private partnerships. Ultimately, his research is driven by a commitment to ensuring that scientific advances reach those most in need, creating a global impact in rare disease care.

Award and Honor🏆

Professor Gareth Baynam has received numerous prestigious awards and honors in recognition of his exceptional contributions to healthcare, research, and innovation. In 2019, he was awarded the Western Australia Minister for Health’s Award—the highest accolade in the WA Health System—for his significant and sustainable impact on population-scale health innovations, particularly benefiting children, youth with rare diseases, and Aboriginal communities. In 2018, he was bestowed with the first Honorary Lifetime Membership of the Genetic and Rare Diseases Network WA (GaRDN), honoring his tireless dedication and collaborative efforts to improve the lives of those affected by genetic and rare diseases. He was also a finalist in the 2019 Premier’s Science Awards, reflecting his prominence in scientific advancement. More recently, in 2024, he was named a finalist for both the Channel 7 Child Health Hero and the NMHS NAIDOC Award, further highlighting his continued excellence in child health advocacy and Indigenous health initiatives.

Research Skill🔬

Professor Gareth Baynam possesses a comprehensive and impactful set of research skills that span clinical genetics, public health, policy development, and translational science. He excels in designing and implementing research frameworks that bridge the gap between cutting-edge science and real-world healthcare delivery, particularly in the context of rare diseases and underserved populations. His skills include leading multi-disciplinary, cross-sectoral collaborations and translating complex genomic research into accessible clinical applications. He is adept in data-driven innovation, combining modern informatics with traditional and community-based knowledge to address health disparities. Professor Baynam demonstrates exceptional ability in stakeholder engagement, having successfully coordinated national and international initiatives involving governments, NGOs, industry partners, and Indigenous communities. He also contributes to health system reforms through policy advising, guideline development, and capacity-building. His research leadership has not only advanced scientific understanding but also ensured that innovations lead to tangible, sustainable improvements in patient care and health equity globally.

Conclusion💡

Professor Gareth Baynam stands out as an exemplary candidate for the Best Researcher Award due to his:

  • Leadership in global health and rare disease research.

  • Multidisciplinary and international contributions.

  • Commitment to equitable, inclusive, and translational science.

  • Recognized excellence through prestigious awards and global collaborations.

He not only meets but exceeds the typical criteria expected for this award. With minor enhancements in showcasing commercialization potential and international collaborations (esp. with Singapore), his profile could serve as a benchmark for impactful, socially conscious scientific leadership.

Publications Top Noted✍️

  • Title: The human phenotype ontology in 2021
    Authors: S Köhler, M Gargano, N Matentzoglu, LC Carmody, D Lewis-Smith, et al.
    Year: 2021
    Citations: 901

  • Title: Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources
    Authors: S Köhler, L Carmody, N Vasilevsky, JOB Jacobsen, D Danis, JP Gourdine, et al.
    Year: 2019
    Citations: 743

  • Title: The human phenotype ontology in 2017
    Authors: S Köhler, NA Vasilevsky, M Engelstad, E Foster, J McMurry, S Aymé, et al.
    Year: 2017
    Citations: 653

  • Title: How many rare diseases are there?
    Authors: M Haendel, N Vasilevsky, D Unni, C Bologa, N Harris, H Rehm, et al.
    Year: 2020
    Citations: 464

  • Title: International cooperation to enable the diagnosis of all rare genetic diseases
    Authors: KM Boycott, A Rath, JX Chong, T Hartley, FS Alkuraya, G Baynam, et al.
    Year: 2017
    Citations: 447

  • Title: The human phenotype ontology in 2017
    Authors: S Kohler, NA Vasilevsky, M Engelstad, E Foster, J McMurry, S Ayme, et al.
    Year: 2017
    Citations: 383

  • Title: Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections
    Authors: AM Bertoli-Avella, E Gillis, H Morisaki, JMA Verhagen, BM De Graaf, et al.
    Year: 2015
    Citations: 341

  • Title: Modeling 3D facial shape from DNA
    Authors: P Claes, DK Liberton, K Daniels, KM Rosana, EE Quillen, LN Pearson, et al.
    Year: 2014
    Citations: 335

  • Title: X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes
    Authors: H Hu, SA Haas, J Chelly, H Van Esch, M Raynaud, APM de Brouwer, et al.
    Year: 2016
    Citations: 330

  • Title: Rights, interests and expectations: Indigenous perspectives on unrestricted access to genomic data
    Authors: M Hudson, NA Garrison, R Sterling, NR Caron, K Fox, J Yracheta, et al.
    Year: 2020
    Citations: 255

  • Title: Future of rare diseases research 2017–2027: an IRDiRC perspective
    Authors: CP Austin, CM Cutillo, LPL Lau, AH Jonker, A Rath, D Julkowska, et al.
    Year: 2017
    Citations: 255

  • Title: The human phenotype ontology: semantic unification of common and rare disease
    Authors: T Groza, S Köhler, D Moldenhauer, N Vasilevsky, G Baynam, T Zemojtel, et al.
    Year: 2015
    Citations: 240

  • Title: Extending the phenotypes associated with DICER1 mutations
    Authors: WD Foulkes, A Bahubeshi, N Hamel, B Pasini, S Asioli, G Baynam, et al.
    Year: 2011
    Citations: 215

  • Title: Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X‐Linked Kabuki Syndrome Subtype 2
    Authors: N Bögershausen, V Gatinois, V Riehmer, H Kayserili, J Becker, et al.
    Year: 2016
    Citations: 197

Kannan Pandian | Agricultural and Biological Sciences | Best Researcher Award

Published on by Global Scholar Awards

Dr. Kannan Pandian | Agricultural and Biological Sciences | Best Researcher Award

Associate Professor at Tamil Nadu Agricultural University, India

Dr. Kannan Pandian is an accomplished researcher in Soil Science and Agricultural Chemistry with expertise in dryland soil resource management, carbon sequestration, and nutrient efficiency enhancement. His research focuses on combating climate vulnerability through carbon and water conservation techniques and developing eco-friendly fertilizers for sustainable agriculture. With over 56 peer-reviewed journal articles, 8 books, 16 book chapters, and two granted patents, he has significantly contributed to soil health, plant nutrition, and precision farming. He has received multiple prestigious awards, including the ICAR-IDP International Faculty Training Fellowship and the Best TNAU Young Scientist Award. His work has been widely recognized at national and international levels, with projects funded by ICAR, DST, and the Tamil Nadu State Development Council.

Professional Profile 

Education

Dr. Kannan Pandian earned his Ph.D. in Soil Science and Agricultural Chemistry from Tamil Nadu Agricultural University (TNAU), Coimbatore, India, in 2007. He completed his Master of Science in the same field from TNAU in 2004 and obtained his Bachelor of Science in Agriculture from TNAU in 2002. His academic journey was marked by excellence, earning several awards, including the Dr. K.K. Krishnamurthy and Dr. G. Selvakumari Medal for Best Doctoral Student and the Prof. T. Balakrishnan Medal for Best Master’s Student. Additionally, he was a recipient of the NADP-RKVY Soil Health Research Fellowship and the Krishnamoorthy International Agricultural Development Foundation Scholarship, highlighting his academic and research proficiency.

Professional Experience

Dr. Kannan Pandian currently serves as an Associate Professor at the Department of Soils and Environment, Tamil Nadu Agricultural University (TNAU). Previously, he held positions as an Assistant Professor at TNAU, a Scientist at the Indian Council of Agricultural Research (ICAR), a Research Associate at the Centre for Soil and Crop Management Studies (CSCMS), and a Senior Research Fellow at TNAU. His research focuses on developing organo-mineral biochar, electrochemical sensor-based soil nutrient assessment, and drought-proofing technologies for rainfed agriculture. He has led multiple externally funded projects, collaborated with premier research institutes, and contributed to significant advancements in soil health management. As a peer reviewer for leading journals and an active member of professional societies, he continues to influence agricultural and biological sciences through his research, innovation, and academic contributions.

Research Interests

Dr. Kannan Pandian’s research primarily focuses on soil health management, carbon sequestration, and nutrient efficiency enhancement to improve agricultural sustainability. His work aims to develop climate-resilient farming techniques, emphasizing biochar technology, drought-proofing methods, and eco-friendly fertilizers. He specializes in dryland soil resource management, precision farming, and electrochemical sensor-based soil nutrient assessment. His studies contribute to mitigating climate change impacts by integrating carbon and water conservation strategies in agroecosystems. Additionally, he explores the role of microbial interactions in soil fertility and plant nutrition, leading to the development of innovative soil amendments. His interdisciplinary research combines soil science, environmental chemistry, and precision agriculture to enhance productivity while ensuring ecological balance. Through collaborations with research institutions and agribusiness sectors, he continuously works towards developing sustainable agricultural practices that can be widely adopted in both rainfed and irrigated farming systems.

Awards and Honors

Dr. Kannan Pandian has received numerous prestigious awards and honors in recognition of his contributions to soil science and sustainable agriculture. He was honored with the Best Young Scientist Award by Tamil Nadu Agricultural University (TNAU) for his innovative work on climate-resilient soil management. His research excellence was further acknowledged with the ICAR-IDP International Faculty Training Fellowship, allowing him to conduct advanced studies at Western Sydney University, Australia. He has also been awarded the Dr. APJ Abdul Kalam Best Teacher Award for his exceptional mentorship and academic contributions. His research papers have received Best Paper and Best Presentation Awards at national and international conferences. Additionally, he holds two granted patents for groundbreaking developments in soil health improvement and precision farming. These accolades underscore his pioneering role in agricultural research, driving innovation and sustainability in the field of soil science.

Research Skills

Dr. Kannan Pandian possesses advanced research skills in soil chemistry, agronomic biochar development, and precision agriculture. He is proficient in electrochemical sensor technology for real-time soil nutrient assessment, enabling accurate and efficient fertilizer application. His expertise in carbon sequestration and climate-smart agriculture allows him to develop strategies for mitigating greenhouse gas emissions in farmlands. He is skilled in GIS-based soil mapping, facilitating spatial analysis of soil properties for better land management. His analytical skills extend to soil fertility modeling, microbial interaction studies, and nutrient cycling research. He is experienced in leading multi-institutional research projects, collaborating with international and national organizations to enhance soil and plant health. His technical proficiency in experimental design, statistical data analysis, and field trials strengthens his research outcomes. His ability to integrate traditional soil science with modern precision technologies makes him a leader in sustainable agriculture and soil conservation research.

Conclusion

Dr. Kannan Pandian is an exceptional candidate for the Best Researcher Award, given his extensive contributions to soil science, sustainable agriculture, and climate resilience. His track record in research, innovation, funding, and academic mentorship makes him a strong contender. Strengthening international collaborations, industry partnerships, and patent commercialization would further elevate his global impact.

Publications Top Noted

  • Towards an operational SAR-based rice monitoring system in Asia: Examples from 13 demonstration sites across Asia in the RIICE project
    Authors: A Nelson, T Setiyono, AB Rala, ED Quicho, JV Raviz, PJ Abonete, …
    Year: 2014
    Citations: 197

  • Effect of biochar amendment on soil physical, chemical and biological properties and groundnut yield in rainfed Alfisol of semi-arid tropics
    Authors: K Pandian, P Subramaniayan, P Gnasekaran, S Chitraputhirapillai
    Year: 2016
    Citations: 178

  • Zinc deficiency in Indian soils with special focus to enrich zinc in peanut
    Authors: P Arunachalam, P Kannan, G Prabukumar, M Govindaraj
    Year: 2013
    Citations: 99

  • Biochar from green waste for phosphate removal with subsequent disposal
    Authors: DK Veni, P Kannan, TNJI Edison, A Senthilkumar
    Year: 2017
    Citations: 94

  • Biological properties of soil as influenced by different organic manures
    Authors: P Kannan, A Saravanan, S Krishnakumar, SK Natarajan
    Year: 2005
    Citations: 82

  • Applying both biochar and phosphobacteria enhances Vigna mungo L. growth and yield in acid soils by increasing soil pH, moisture content, microbial growth and P availability
    Authors: P Kannan, M Paramasivan, S Marimuthu, C Swaminathan, J Bose
    Year: 2021
    Citations: 73

  • Drought assessment and monitoring through remote sensing and GIS in western tracts of Tamil Nadu, India
    Authors: D Muthumanickam, P Kannan, R Kumaraperumal, S Natarajan, …
    Year: 2011
    Citations: 57

  • Organic farming on tomato yield and quality
    Authors: P Kannan, A Saravanan, T Balaji
    Year: 2006
    Citations: 57

  • Rice crop monitoring and yield estimation through COSMO Skymed and TerraSAR-X: A SAR-based experience in India
    Authors: S Pazhanivelan, P Kannan, P Christy Nirmala Mary, E Subramanian, …
    Year: 2015
    Citations: 38

  • Implication of micronutrients in agriculture and health with special reference to iron and zinc
    Authors: M Govindaraj, P Kannan, P Arunachalam
    Year: 2011
    Citations: 36

Girish C. Melkani | Genetics | Best Researcher Award

Published on by Global Scholar Awards

Prof. Girish C. Melkani | Genetics | Best Researcher Award

Professor at UAB HEERSINK SCHOOL OF MEDICINE, United States

Dr. Girish C. Melkani, an Associate Professor of Pathology at the University of Alabama at Birmingham (UAB), is a prominent researcher in the fields of circadian biology, cardiovascular health, and aging. With a background in chemistry and molecular biology, Dr. Melkani has contributed significantly to understanding the mechanisms linking circadian rhythms, metabolic disorders, and age-related diseases. His work leverages Drosophila (fruit fly) models to investigate the molecular basis of cardiac, muscular, and neurodegenerative diseases, with a focus on optimizing lifestyle interventions like Time-Restricted Feeding (TRF) to counteract these conditions. Supported by multiple NIH grants, Dr. Melkani’s research examines gut-brain signaling in Alzheimer’s disease and explores the connections between insomnia and cardiovascular disease. An active member in scientific communities, he holds leadership roles at UAB’s Nathan Shock Center and is widely recognized for his expertise, with numerous invited talks and influential publications shaping translational approaches in biomedical research.

Professional Profile

Education

Dr. Girish C. Melkani has an impressive academic background that has laid the foundation for his research career in pathology and circadian biology. He earned his Bachelor of Science degree in Chemistry from the University of Pune in India, where he developed a strong foundation in the sciences. He then pursued his Ph.D. in Molecular Biology at the University of Illinois at Urbana-Champaign, where he focused on understanding complex biological systems. Following his doctoral studies, Dr. Melkani completed a postdoctoral fellowship at the National Institute of Health (NIH), where he further honed his research skills and expertise in metabolic disorders and circadian rhythms. His education and training have equipped him with a diverse skill set, allowing him to make significant contributions to the fields of cardiovascular health and aging. Dr. Melkani’s academic journey reflects a commitment to advancing scientific knowledge and fostering interdisciplinary collaboration in biomedical research.

Professional Experience

Prof. Girish C. Melkani boasts a distinguished career in academia and research, significantly contributing to the fields of pathology and circadian biology. He currently serves as a faculty member at Texas A&M University, where he leads research focused on metabolic disorders, aging, and the impact of circadian rhythms on health. Prior to this position, Prof. Melkani held postdoctoral roles at the National Institute of Health (NIH), where he investigated the molecular mechanisms underlying cardiovascular diseases and metabolic health. His research has garnered recognition and funding from prestigious institutions, allowing him to publish numerous influential papers in high-impact journals. Additionally, Prof. Melkani is actively involved in mentoring graduate students and postdoctoral researchers, fostering the next generation of scientists. His dedication to education and research is evident in his collaborative efforts to integrate interdisciplinary approaches in understanding complex biological systems, making a lasting impact in his field.

Research Interests

Prof. Girish C. Melkani’s research interests lie at the intersection of metabolic disorders, aging, and circadian biology. He is particularly focused on understanding how circadian rhythms influence metabolic processes and contribute to the pathophysiology of various diseases, including obesity and diabetes. His work investigates the molecular mechanisms that regulate circadian clocks in metabolic tissues, exploring how disruptions in these rhythms can lead to metabolic dysregulation. Prof. Melkani employs advanced experimental techniques, including genetic models and high-throughput screening, to dissect the complex interactions between circadian signaling and metabolic pathways. Additionally, he is interested in the role of lifestyle factors, such as diet and exercise, in modulating circadian rhythms and their implications for health. Through his research, he aims to uncover novel therapeutic targets for preventing and treating metabolic disorders, contributing to a deeper understanding of how circadian biology affects overall health and longevity.

Awards and Honors

Prof. Girish C. Melkani has received numerous awards and honors in recognition of his significant contributions to the fields of metabolic research and circadian biology. He was awarded the prestigious Young Investigator Award by the Society for Experimental Biology, acknowledging his innovative research on the relationship between circadian rhythms and metabolic disorders. Additionally, he has been honored with the National Science Foundation Research Grant, which supports his ongoing studies into the molecular mechanisms underlying metabolic dysregulation. His work has also been recognized by various academic institutions, where he received accolades for his commitment to mentoring students and fostering research collaborations. Prof. Melkani has published extensively in high-impact journals, further establishing his reputation as a leading researcher in his field. His dedication to advancing scientific knowledge and addressing metabolic health issues has not only earned him respect among peers but also positioned him as a key figure in the academic community.

Conclusion

Dr. Melkani’s impressive academic background, innovative research, leadership roles, and commitment to mentorship and collaboration make him an exceptional candidate for the Best Researcher Award. His work has the potential to significantly impact our understanding of complex biological systems and translate these findings into meaningful health interventions.

Publication Top Noted

  • Title: Automated assessment of cardiac dynamics in aging and dilated cardiomyopathy Drosophila models using machine learning

    Authors: Melkani, Y., Pant, A., Guo, Y., Melkani, G.C.

    Year: 2024

    Citation: Communications Biology, 7(1), 702

  • Title: Genetic and Pathophysiological Basis of Cardiac and Skeletal Muscle Laminopathies

    Authors: Bhide, S., Chandran, S., Rajasekaran, N.S., Melkani, G.C.

    Year: 2024

    Citation: Genes, 15(8), 1095

  • Title: Diurnal expression of Dgat2 induced by time-restricted feeding maintains cardiac health in the Drosophila model of circadian disruption

    Authors: Guo, Y., Abou Daya, F., Le, H.D., Panda, S., Melkani, G.C.

    Year: 2024

    Citation: Aging Cell, 23(7), e14169

  • Title: O-GlcNAc transferase regulates collagen deposition and fibrosis resolution in idiopathic pulmonary fibrosis

    Authors: Vang, S., Helton, E.S., Guo, Y., Krick, S., Barnes, J.W.

    Year: 2024

    Citation: Frontiers in Immunology, 15, 1387197

  • Title: Time-restricted feeding regulates lipid metabolism under metabolic challenges

    Authors: Guo, Y., Livelo, C., Melkani, G.C.

    Year: 2023

    Citation: BioEssays, 45(12), 2300157

  • Title: Time-restricted feeding promotes muscle function through purine cycle and AMPK signaling in Drosophila obesity models

    Authors: Livelo, C., Guo, Y., Abou Daya, F., Panda, S., Melkani, G.C.

    Year: 2023

    Citation: Nature Communications, 14(1), 949

  • Title: When a calorie is not just a calorie: Diet quality and timing as mediators of metabolism and healthy aging

    Authors: Mihaylova, M.M., Chaix, A., Delibegovic, M., Panda, S., Lamming, D.W.

    Year: 2023

    Citation: Cell Metabolism, 35(7), 1114–1131

  • Title: Mitochondrial epigenetic modifications and nuclear-mitochondrial communication: A new dimension towards understanding and attenuating the pathogenesis in women with PCOS

    Authors: Shukla, P., Melkani, G.C.

    Year: 2023

    Citation: Reviews in Endocrine and Metabolic Disorders, 24(2), 317–326

  • Title: Circadian-mediated regulation of cardiometabolic disorders and aging with time-restricted feeding

    Authors: Roth, J.R., Varshney, S., de Moraes, R.C.M., Melkani, G.C.

    Year: 2023

    Citation: Obesity, 31(S1), 40–49

  • Title: Rapamycin reduces neuronal mutant huntingtin aggregation and ameliorates locomotor performance in Drosophila

    Authors: Roth, J.R., Moraes, R.C.M.D., Xu, B.P., Khan, M.A., Melkani, G.C.

    Year: 2023

    Citation: Frontiers in Aging Neuroscience, 15, 1223911